Substance Abuse

Opioid Dependence Prevention Treatments Compared

Opioid Dependence Prevention Treatments Compared

By

Significantly less heroin cravings were reported in the extended-release naltrexone group and treatment satisfaction was also reported higher in this group compared to the buprenorphine-naloxone group.

Long-Term Pharmacotherapy Strategies for Substance Use Disorder Management

Long-Term Pharmacotherapy Strategies for Substance Use Disorder Management

By

New pharmacotherapies in combination with psychotherapy and counseling have proven effective in preventing relapse.

FDA Approves Marketing of Substance Abuse Treatment App

FDA Approves Marketing of Substance Abuse Treatment App

The FDA has permitted marketing of the first mobile app to help treat substance abuse use disorders, including alcohol, cocaine, marijuana, or other stimulants.

Man Complains of Leg Pain, Nausea, and Malaise

Man Complains of Leg Pain, Nausea, and Malaise

By

A 39-year-old man presents to the emergency department with 3 days of progressive bilateral leg pain, nausea, malaise, and no other symptoms. What additional tests should you order to make a correct diagnosis?

CBT to Reduce Substance Abuse, PTSD in Transgender Women With HIV

CBT to Reduce Substance Abuse, PTSD in Transgender Women With HIV

By

A 12-week CBT program led to reductions in PTSD and substance abuse in transgender women with HIV.

Extended-Release Oxycodone/Acetaminophen: Overview of a Novel Opioid

Extended-Release Oxycodone/Acetaminophen: Overview of a Novel Opioid

By

CPA reports on a new analgesic formulation designed to provide both immediate and prolonged analgesia for up to 12 hours in patients with acute pain.

Sign Up for Free e-Newsletters